Newsletter mensile Aiom
Anno III – Numero 26 – Dicembre 2020
Comitato scientifico editoriale: Vanna Chiarion Sileni, Paola Queirolo
Editore: Intermedia, Direttore Responsabile: Mauro Boldrini
 
Notizie dalla ricerca


ESMO consensus conference recommendations on the management of metastatic melanoma: under the auspices of the ESMO Guidelines Committee


The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. The aim of the conference was to develop recommendations on topics that are not covered in detail in the current ESMO …
Continua a leggere


 

ESMO consensus conference recommendations on the management of locoregional melanoma: under the auspices of the ESMO Guidelines Committee

The European Society for Medical Oncology (ESMO) held a consensus conference on melanoma on 5-7 September 2019 in Amsterdam, The Netherlands. The conference included a multidisciplinary panel of 32 leading experts in the management of melanoma. The aim of the conference was to develop recommendations on topics that are not covered in detail in the current ESMO …
Continua a leggere


 

Electrochemotherapy in the treatment of cutaneous malignancy: Outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008-2019)

Electrochemotherapy (ECT) is a treatment for both primary and secondary cutaneous tumours. The international Network for sharing practices on ECT group investigates treatment outcomes after ECT using a common database with defined parameters. Twenty-eight centres across Europe prospectively uploaded data over an 11-year period. Response rates were investigated in relation to primary …
Continua a leggere


 

Melanoma brain metastases – Interdisciplinary management recommendations 2020

Melanoma brain metastases (MBM) are common and associated with a particularly poor prognosis; they directly cause death in 60-70% of melanoma patients. In the past, systemic treatments have shown response rates around 5%, whole brain radiation as standard of care has achieved a median overall survival of approximately three months. Recently, the combination of immune checkpoint …
Continua a leggere


 

The concepts of rechallenge and retreatment in melanoma: A proposal for consensus definitions

Patients with BRAF-mutant melanoma commonly develop resistance to BRAF inhibitor and MEK inhibitor (BRAF/MEKi) treatment, resulting in disease recurrence or progression. Repeated treatment after a break or an intervening therapy may provide clinical benefit. To ensure a common understanding when discussing the treatment of BRAF-mutant melanoma, we propose consensus definitions for …
Continua a leggere


 

The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force

The incidence of skin cancers has been increasing steadily over the last decades. Although there have been significant breakthroughs in the management of skin cancers with the introduction of novel diagnostic tools and innovative therapies, skin cancer mortality, morbidity and costs heavily burden the society. Members of the European Association of Dermato-Oncology, European Academy of Dermatology …
Continua a leggere

 

Appuntamenti Aiom


Avviso a tutti i Soci

A causa del protrarsi dell’emergenza coronavirus e delle relative disposizioni, si suggerisce di verificare la conferma dei singoli eventi direttamente con gli organizzatori

Supportive Care: The Big One
Corso FAD ECM 14 settembre 2020 – 14 settembre 2021
Iscrizioni aperte per tutta la durata del corso

L’Adroterapia e l’Importanza della Multidisciplinarietà per una Terapia Personalizzata
FAD, 5 ottobre – 31 dicembre 2020
Registrazione e-learning dal 13 settembre al 31 dicembre 2020

Il Trattamento Multidisciplinare dei Tumori del Distretto Testa-Collo: un Approccio Pratico
FAD, 20 gennaio 2021

Nutrizione in Oncologia
Master Universitario di II livello, Anno Accademico 2020/2021
Università degli Studi di Pavia
Procedura di ammissione da completare entro il 25 gennaio 2021

11th Milan Congress on Innovative Anticancer Therapy
FAD, 21 – 22 gennaio 2021

Il Trattamento Multidisciplinare dei Tumori del Distretto Testa-Collo: un Approccio Pratico
FAD, 27 gennaio 2021

Il Paziente Oncologico in Pronto Soccorso
Belluno, 27 gennaio 2021

La Ricerca in Oncologia dopo il Covid-19 tra Problematiche e Opportunità
Convegno GOIRC 2021
FAD, 26 – 27 febbraio 2021
Questi e altri appuntamenti si possono consultare sul sito AIOM: www.aiom.it


© 2020 Editore: 
Intermedia srl Via Malta 12/B Brescia, BS 25124 Italy
tel. 030 226105 – Reg. Trib. di Brescia n. 35/2001 del 2/7/2001
Iscrizione al Registro degli Operatori di Comunicazione N. 4867

Per contattare la redazione e commentare le notizie clicca qui
Per consultare i numeri arretrati della newsletter clicca qui

Ricevi questa email perché sei iscritto alla newsletter AIOM Cancellati


Si ringrazia Pierre Fabre Pharma s.r.l. per il supporto incondizionato